Endometriosis
Reproductive·MeSH: Endometriosis
Prevalence
5000.0 / 100K
Incidence
300.0 / 100K/yr
8 drugs in development·7 companies·8 clinical trials
Drug Pipeline by Phase
Approved(1)
Phase 3(2)
Phase 2(3)
Phase 1(1)
| Drug | Company |
|---|---|
| elagolix | AbbVie Inc. (ABBV) |
Preclinical(1)
| Drug | Company |
|---|---|
| ABS-201 | Absci Corporation (ABSI) |
Compare drugs
Frequently asked questions
How many drugs are in development for Endometriosis?
BioSniper tracks 8 drugs in development for Endometriosis across 7 companies.
How many clinical trials target Endometriosis?
There are 8 clinical trials targeting Endometriosis tracked by BioSniper.
What is the prevalence of Endometriosis?
The estimated prevalence of Endometriosis is approximately 5000.0 per 100,000 population.
Deep-dive into Endometriosis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis